| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42dcb8afd289e295b65f450020cbfdb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42d51b816cf061cfb071bd1741b3d6bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e7732a9aeefd843b50a8ffebb19146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ddb80331bc9bcf67ef8d64519aef6cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184fbda0566f4bdb29ce22ce9df404c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7ec233764144d72ecd9b64884b750c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29e32af0fe2b221bd5b5a6bbdc32c764
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608ed5a6668bee519765cada6e3f624b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43952c9d25af5d0d751576e39b626392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f31daa92fdaa7765855daf162b9cd414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_074603c729519822a46cd3a7dd352b75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5521d2b907790cfd0bf3f85973390c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bc3e4fc80f4387e5936af2304be659a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bd93a3dfd6cdd319b7e4c3bc96c9fce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59e6487fcd0a8b2828f1f98a99e7d5fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4081fdc021c694d714177ac4d2f612ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_408e95271330cd51c0d0c412b546bbb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b002a6ab69f1d89f9b26139d361104e9 |
| publicationDate |
2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201109328-A |
| titleOfInvention |
Methods for treating cancer and non-neoplastic conditions |
| abstract |
Compounds that selectively inhibit pathological production of human vascular endothelial growth factor (VEGF) and compositions comprising such Compounds are described. Compounds that inhibit viral replication and compositions comprising such Compounds are described. Also described are methods of reducing VEGF using such Compounds and methods for treating cancer and non-neoplastic conditions involving the administration of such Compounds. Further described are methods of inhibiting viral replication using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments. |
| priorityDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |